Picture of Cohance Lifesciences logo

COHANCE — Cohance Lifesciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Suven Pharmaceuticals Executed Definitive Agreements For Acquiring 100% Of Shares In Sapala Organics

June 13 (Reuters) - Suven Pharmaceuticals Ltd  SUVH.NS :
    * EXECUTED DEFINITIVE AGREEMENTS FOR ACQUIRING 100% OF
SHARES IN
SAPALA ORGANICS
    * DEAL FOR 2.3 BILLION RUPEES
    * CO AGREED TO INITIALLY ACQUIRE 67.5% BY WAY OF SECONDARY
TRANSFER FROM SAPALA ORGANICS EXISTING SHAREHOLDERS

Source text for Eikon:  ID:nBSE3qYcqh 
Further company coverage:  SUVH.NS 

 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Cohance Lifesciences

See all news